- Product Details
Keywords
- Ponatinib 943319-70-8
- Ponatinib supplier
- Ponatinib seller
Quick Details
- ProName: Ponatinib
- CasNo: 943319-70-8
- Molecular Formula: C29H27F3N6O
- Application: only for research
- DeliveryTime: 2 weeks
- PackAge: according to the request of customer
- Port: Ji nan;
- ProductionCapacity: 1 Kilogram/Month
- Purity: 99%
- Storage: Low temperature dry and shady
- Transportation: according to the request of customer
- LimitNum: 1 Gram
Superiority
We have been providing over 1000 products including molecular targeted anticancer drugs, cell signaling pathway inhibitors,
pharmaceutical intermediates, and heterocyclic compounds, and quality services including custom synthesis, transfer of new
drug patent and technology, technical cooperation, and process optimization.
Details
Year Establishment: 2008
Location: At one of the largest National Technical Integrated Drug Discovery Platforms in the High-Tech Zone of Jinan City
Our company was founded by a core group of top overseas pharmaceutical chemists, medical scientists business
management experts
We have built up solid cooperation with over twenty oversea companies over one hundred domestic companies
since the foundation
Specifications:
Name Ponatinib
Synonyms AP 24534; 3-(2-Imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-[4-[(4-methyl-1-piperazinyl)methyl]-3-(trifluoromethyl)phenyl]benzamide
Molecular Formula C29H27F3N6O
Molecular Weight 532.56
CAS Registry Number 943319-70-8
Applications:
AP24534 is a novel potent,ally available small molecule multitargeted kinase inhibitwith IC50 of 0.37, 2, 1.5, 2.2, 1.1, 10.24 nM fnative pan-BCR-ABL, mutated form, VEGFR2, FGFR1, PDGFRα, mutant FLT3 phosphorylation LYN.